Finerenone in Patients with Severe Heart Failure: The FINEARTS-HF Trial
Among patients with mildly reduced or preserved LVEF, severe HF was associated with a heightened risk of CV events. Treatment with finerenone appeared safe and effective, regardless of HF severity.
Authors
- Andrea Glasauer
- Sanjiv J. Shah (ORCID: https://orcid.org/0000-0002-5655-8201)
- Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
- Orly Vardeny (ORCID: https://orcid.org/0000-0002-6387-1351)
- Pardeep S. Jhund (ORCID: https://orcid.org/0000-0003-4306-5317)
- James Lay‐Flurrie
- John J.V. McMurray (ORCID: https://orcid.org/0000-0002-6317-3975)
- Alasdair Henderson (ORCID: https://orcid.org/0000-0002-8903-4906)
- Riccardo Maria Inciardi (ORCID: https://orcid.org/0000-0003-4846-8529)
- Kavita Sharma (ORCID: https://orcid.org/0000-0002-4264-1717)
- Muthiah Vaduganathan (ORCID: https://orcid.org/0000-0003-0885-1953)
- Andrea Scalise (ORCID: https://orcid.org/0000-0002-9367-5773)
- Henri Lu (ORCID: https://orcid.org/0000-0002-9074-6505)
- Béla Péter Merkely (ORCID: https://orcid.org/0000-0001-6514-0723)
- Subodh Verma
- Min Miao (ORCID: https://orcid.org/0000-0002-7140-9749)
- Adriaan A. Voors
- Akshay S. Desai
- Scott Solomon
- Faiez Zannad
- Bertram Pitt
- Michele Senni
- Mark C Petrie
- Flaviana Amarante
Institutions
- Semmelweis University (HU)
- Northwestern University (US)
- Brigham and Women's Hospital (US)
- St. Michael's Hospital (CA)
- University of Minnesota (US)
- University Medical Center Groningen (NL)
- Harvard University (US)
- Johns Hopkins University (US)
- Bayer (United States) (US)
- Inserm (FR)
- National University of Singapore (SG)
- University of Groningen (NL)
- University of Toronto (CA)
- University of Michigan (US)
- Johns Hopkins Medicine (US)
- Canada Research Chairs (CA)
- Centre Hospitalier Universitaire Vaudois (CH)
- British Heart Foundation (GB)
- Surgical Specialties (Canada) (CA)
- Ospedale Papa Giovanni XXIII (IT)
- National University Heart Centre Singapore (SG)
- Michigan Medicine (US)
- Minneapolis VA Health Care System (US)
- St Michael's Hospital (GB)
- National Heart Centre Singapore (SG)
- Bayer (United Kingdom) (GB)
- French Clinical Research Infrastructure Network (FR)
- University of Milano-Bicocca (IT)
- Bayer (Germany) (DE)
- University of Glasgow (GB)
- University of Brescia (IT)
- Université de Lorraine (FR)
- University of Lausanne (CH)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1002/ejhf.70083
- Citations
- 1
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Bayer